logo

For the Inventor, By the Inventor

Burlington, MA, United States of America

Dyax Corporation


USPTO Granted Patents = 173



Trademarks = 5

Forward Citations = 2,809

Loading Chart...
Loading Chart...

221 inventors (with patents filed for the assignee):

goldMedal Robert Charles Ladner (85 out of 107 patents)

silverMedal Arthur Charles Ley (24 out of 30 patents)

bronzeMedal Daniel T Dransfield (23 out of 24 patents)

4.  Daniel J Sexton (20 out of 42 patents)

5.  Aaron Sato (20 out of 77 patents)

6.  William Markland (20 out of 27 patents)

7.  Simon E Hufton (14 out of 14 patents)

8.  Rene Hoet (13 out of 23 patents)

9.  Peter C Van Davelaar (13 out of 22 patents)

10.  Anthony Williams (12 out of 13 patents)

11.  Malini Viswanathan (11 out of 20 patents)

12.  Hendricus Renerus Jacobus Mattheus Hoogenboom (11 out of 28 patents)

13.  Palaniappa Nanjappan (11 out of 34 patents)

14.  Clive R Wood (11 out of 37 patents)

15.  Shirish Hirani (10 out of 11 patents)


Core Competencies:
Nucleic Acids
Anti-Neonatal Fc Receptor Antibodies
Immunoassay Techniques
Monoclonal Antibodies
Genetic Libraries
Plasma Protease Inhibitors
Kallikrein Inhibitors
Autoimmune Disease Treatment
Eukaryotic Display Vectors
Diabetic Macular Edema
Ligand Screening
Therapeutic Constructs

173 patents:

1. 11014988 - Nucleic acids encoding anti-neonatal Fc receptor (FcRn) antibodies (2021-05-25),
2. 10914747 - Immunoassay to detect cleaved high molecular weight kininogen (2021-02-09),
3. 10913802 - Monoclonal antibody inhibitor of factor XIIA (2021-02-09),
4. 10870115 - Evacuated blood collection tubes containing protease inhibitors for the assessment of contact system activation (2020-12-22),
5. 10829541 - Methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries (2020-11-10),
6. 10718066 - Libraries of genetic packages comprising novel HC CDR3 designs (2020-07-21),
7. 10690670 - Assays for determining levels of plasma protease C1 inhibitor (2020-06-23),
8. 10683342 - Libraries of genetic packages comprising novel HC CDR1, CDR2, and CDR3 and novel LC CDR1, CDR2, and CDR3 designs (2020-06-16),
9. 10648990 - Diagnosis and treatment of autoimmune diseases (2020-05-12),
10. 10604753 - Focused libraries of genetic packages (2020-03-31),
11. 10577599 - Multi-chain eukaryotic display vectors and uses thereof (2020-03-03),
12. 10577598 - Display library process (2020-03-03),
13. 10479834 - Fc receptor antibodies and methods of use thereof (2019-11-19),
14. 10428158 - Compositions and methods for treatment of diabetic macular edema (2019-10-01),
15. 10370453 - Plasma kallikrein binding proteins (2019-08-06),
Dyax Corporation is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapies for patients with rare diseases. With a strong emphasis on research and development, Dyax is dedicated to addressing unmet medical needs and improving the lives of patients worldwide.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

...
173 Patents

#3 in Burlington, MA

#125 in Massachusetts

#2,238 in US

#4,655 in the World

...
Burlington, MA, United States of America

Dyax Corporation

Forward Citations = 2,809

221 inventors:

goldMedal Robert Charles Ladner (85 out of 107 patents)

silverMedal Arthur Charles Ley (24 out of 30 patents)

bronzeMedal Daniel T Dransfield (23 out of 24 patents)

4.  Daniel J Sexton (20 out of 42 patents)

5.  Aaron Sato (20 out of 77 patents)

Please report any incorrect information to support@idiyas.com
Loading…